维普期刊资源整合服务平台（V6.5）

251篇 您的检索式：作者名="Motzer R"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study显示文摘	Olivier Rixe Ronald M Bukowski M Dror Michaelson George Wilding Gary R Hudes Oliver Bolte Robert J Motzer Paul Bycott Katherine F Liau James Freddo Peter C Trask Sinil Kim Brian I Rini	2007	Lancet Oncology2007，，：	2
2	Sunitinib versus interferon alfa in metastatic renal cell carcinoma 显示文摘	Motzer R J Hutson TE Tomczak P	2007	N Engl J Med2007，356，2：	1
3	Activity of SUl1248, a muhitargeted inhibitor of vascular endothelial growth faclor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘	Motzer R J Michaelson MD Redman BG	2006	J Clin Oncol2006，24，1：	1
4	Sunitinib in patients with metastatic renal cell carcinoma显示文摘	MOTZER R J RINI B I BUKOWSKI R M	2006	JAMA2006，295，21：	1
5	Sunitinib versus interferon alfa in metastatic renal cell carcinoma 显示文摘	Motzer R J Hutson TE Tomczak P	2007	N Engl J Med2007，356，11：	1
6	Efficacy ofeverolimus in advanced renal cell carcinoma : a double,Blind randomised, placebo controlled phase HI trial显示文摘	Motzer R J Escudier B Oudard S	2008	Lancet2008，372，44：	1
7	Renal cell carcinoma显示文摘	Motzer R J Bander N H Nanus D M	1996	N Engl J Med1996，335，：	1
8	Cutaneous side-effects in cancer patients treated with the anti epidermal growth factor receptor antibody C225显示文摘	Busam K J Capodieci P Motzer R	2001	Br J Dermatol2001，144，6：	1
9	Sunitinib versus interferon alfa in metastatic renal-cell carcinoma显示文摘	MOTZER R J HUTSON T E TOMCZAK P	2007	N Engl J Med2007，356，2：	1
10	Renal-cell carcinoma 显示文摘	Motzer R] Bander NH Nanus DM	1996	N Engl J Med1996，335，12：	1
11	Sunitinib efficacy against advanced renal cell carcinoma 显示文摘	Motzer R J Michaelson MD Rosenberg J	2007	J Urol2007，178，5：	1
12	Suni- tinib versus interferon alfa in metastatic renal-cell carcinoma显示文摘	MOTZER R J HUTSON T E TOMCZAK P	2007	N Engl J Med2007，356，2：	1
13	Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma显示文摘	Motzer R J Hutson TE Tomczak P	2009	J Clin Onco12009，27，22：	1
14	Sunitinib in patients with metastatic renal cell carcinoma 显示文摘	Motzer R J Rini BI Bukowski RM	2006	JAMA2006，295，21：	1
15	Kidney cancer,the national comprehensive cancer network (NCCN) practice guidelines 显示文摘	Motzer R J Bolger GB Boston B	2007	Oncology2007，1，：	1
16	Sunitinib versus interferon alfa in metastatic renal-cell carcinoma 显示文摘	Motzer R J Hutson TE Tomczak P	2007	N Engl J Med2007，356，2：	1
17	Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma显示文摘	Motzer R J Hutson T E Tomczak P	2009	J Clin Oncol2009，27，22：	1
18	Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma 显示文摘	Motzer R J Michaelson M D Redman B G	2006	J CIin Oncol2006，24，1：	1
19	Efficacy of everolimus in advanced renal cell carcinoma:a double-blind, randomised,placebo-controlled phaseⅢtrial显示文摘	MOTZER R ESCUDIER B OUDARD S	2008	Lancet2008，372，9637：	1
20	Sunitinib in pa- tients with metastatic renal cell carcinoma 显示文摘	Motzer R J Rini BI Bukowski RM	2006	JAMA2006，295，21：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示